Precision Clinical Medicine
Scope & Guideline
Navigating the complexities of personalized treatment.
Introduction
Aims and Scopes
- Precision Oncology:
The journal emphasizes the development and application of precision medicine strategies in oncology, including the use of biomarkers, genomic profiling, and personalized treatment plans to enhance cancer care. - Multi-Omics Approaches:
There is a strong focus on multi-omics methodologies, integrating genomics, transcriptomics, proteomics, and metabolomics to understand complex diseases and develop targeted interventions. - Innovative Therapeutics:
Research on novel therapeutic strategies, including gene therapy, immunotherapy, and small-molecule drugs, is a key area of interest, with an emphasis on their application in precision medicine. - Artificial Intelligence and Machine Learning:
The utilization of AI and machine learning techniques for data analysis, predictive modeling, and enhancing diagnostic accuracy is a prominent theme in the journal. - Translational Research:
The journal aims to bridge the gap between laboratory research and clinical application, promoting studies that translate basic science discoveries into practical clinical solutions. - Chronic Disease Management:
There is a focus on understanding and managing chronic diseases such as diabetes, cardiovascular diseases, and inflammatory bowel diseases through precision medicine approaches.
Trending and Emerging
- Exosomal and Circulating Biomarkers:
There is an increasing emphasis on the role of exosomal and circulating biomarkers in disease diagnosis and prognosis, particularly in cancer and metabolic diseases, highlighting their potential as non-invasive diagnostic tools. - Integrative Machine Learning Applications:
The application of advanced machine learning techniques for data integration and predictive modeling in clinical settings is on the rise, showcasing the journal's commitment to leveraging technology for improved patient outcomes. - Gut Microbiota and Disease Interactions:
Research exploring the influence of gut microbiota on various diseases, including inflammatory bowel disease and metabolic disorders, is becoming more prominent, reflecting a growing interest in the microbiome's role in precision medicine. - Immunotherapy Innovations:
The journal is increasingly publishing studies on novel immunotherapeutic approaches, indicating a rising trend in the exploration of immune-based treatments for cancer and autoimmune diseases. - Personalized Approaches to Chronic Diseases:
There is a notable increase in research focused on personalized strategies for managing chronic diseases, including diabetes, cardiovascular diseases, and neurodegenerative disorders, aligning with the journal's precision medicine goals.
Declining or Waning
- Traditional Single-Omics Studies:
Research that relies solely on single-omics approaches has become less prominent as the field moves towards integrated multi-omics studies for more comprehensive insights into disease mechanisms. - General Population Health Studies:
While population health remains important, there is a noticeable decrease in studies that do not apply precision medicine principles, as the journal prioritizes research with specific, targeted clinical applications. - Basic Science Without Clinical Relevance:
Papers focused on basic science without a clear translational or clinical application have become less frequent, as the journal increasingly favors studies that demonstrate direct relevance to patient care. - Non-Genomic Biomarkers:
The exploration of non-genomic biomarkers has waned, possibly due to the growing prominence of genomic and molecular markers that offer more precise insights into disease processes. - Aging Research:
While still relevant, traditional aging research has seen a decline in focus within the context of precision medicine, as the journal shifts towards more specific applications of precision approaches in age-related diseases.
Similar Journals
Journal of Personalized Medicine
Leading the charge in tailored healthcare advancements.Journal of Personalized Medicine is a pioneering open-access journal published by MDPI, renowned for its commitment to advancing research in the dynamic field of personalized healthcare. Since its inception in 2011, this journal has served as a critical platform for scholars, practitioners, and students interested in the integration of individualized therapies and diagnostic techniques that aim to tailor medical treatments to the unique characteristics of each patient. With an impressive Q2 ranking in the field of medicine, as recognized by Scopus, and currently holding a percentile rank of 65th, it stands out among its peers with a focus on innovative approaches that challenge traditional paradigms. Researchers can benefit from its open-access model, allowing for broader dissemination of findings that can significantly impact clinical practices and research directions globally. Set against the picturesque backdrop of Basel, Switzerland, the journal is positioned at the forefront of medical innovation, producing high-quality, peer-reviewed articles that span the latest advancements and applications in personalized medicine.
Global Medical Genetics
Connecting Genetics to Personalized MedicineGlobal Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.
Genome Medicine
Connecting Genetics to Clinical ExcellenceGenome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.
Circulation-Genomic and Precision Medicine
Advancing Precision in Cardiovascular CareCirculation-Genomic and Precision Medicine is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, dedicated to advancing the fields of cardiology, cardiovascular medicine, and genetics. With an impressive impact factor and ranked in the Q1 quartile across multiple categories, including Cardiology and Genetics, this journal is pivotal for researchers and professionals seeking the latest insights and advancements in precision medicine. Established in 2018, it has rapidly gained recognition, evidenced by its commendable Scopus ranking and high percentiles among related fields. The journal emphasizes open access to enhance the dissemination of knowledge, making cutting-edge research readily available to a global audience. With the convergence of genomic science and cardiovascular health, Circulation-Genomic and Precision Medicine aims to foster interdisciplinary collaborations, offering a vital platform for innovative studies that impact patient care and clinical practices.
Cancer Management and Research
Illuminating the complexities of oncology for better health.Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.
Communications Medicine
Bridging the gap between research and practice in medicine.Communications Medicine is a leading journal in the interdisciplinary field of medical communications, published by SpringerNature. Dedicated to advancing the scientific exchange of knowledge, this journal aims to facilitate the dissemination of innovative research, pivotal findings, and critical discussions that shape patient care and healthcare practices globally. With a commitment to open-access publishing, Communications Medicine ensures that cutting-edge health research is easily accessible to professionals, researchers, and students alike, fostering collaborative efforts across various medical disciplines. Although the current impact factor and specific metrics such as HIndex and Scopus ranks are not available, the journal's reputation and association with SpringerNature, renowned for its robust academic publishing, solidify its importance as a valuable resource in the ever-evolving landscape of medical communications. Researchers interested in engaging with the latest advancements and contributing to the dialogue surrounding health technologies and methodologies will find this journal an essential platform for their work.
JCO Precision Oncology
Unraveling Cancer's Complexity with Precision ScienceJCO Precision Oncology, published by Lippincott Williams & Wilkins, is a leading journal in the field of cancer research and oncology, recognized for its high-impact contributions and innovative approaches to precision medicine. Since its inception in 2017, this journal has consistently ranked in the Q1 category in both Cancer Research and Oncology for 2023, reflecting its esteemed position within the academic community. With a rigorous peer-review process and a focus on disseminating cutting-edge research, JCO Precision Oncology serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to enhance the understanding and treatment of cancer through individualized therapies. The journal's comprehensive scope includes studies on genetic profiling, biomarker research, and novel therapeutic strategies, making it an essential resource for anyone involved in cancer care and research. Explore further and join a community committed to advancing precision oncology and improving patient outcomes.
Precision and Future Medicine
Shaping healthcare innovation one study at a time.Precision and Future Medicine is an esteemed academic journal published by Sungkyunkwan University School of Medicine, dedicated to advancing the fields of precision medicine and healthcare innovation. Established as an Open Access journal in 2017, it aims to disseminate cutting-edge research and insights that bridge the gap between basic and clinical sciences. With a focus on personalized medicine, genomics, and advanced therapeutic strategies, the journal serves as a vital resource for researchers, clinicians, and policy makers. Set in the dynamic environment of South Korea, Precision and Future Medicine provides a platform for the exchange of ideas that are shaping the future of medical science, thus contributing significantly to the global dialogue on health and wellness. As it continues to grow, the journal is committed to ensuring that high-quality research remains accessible to all, fostering a spirit of collaboration and innovation within the scientific community.
npj Precision Oncology
Unlocking Insights for Precision Medicinenpj Precision Oncology, an esteemed peer-reviewed journal published by NATURE PORTFOLIO, stands at the forefront of oncological research and precision medicine. Launched as an Open Access platform in 2017, this journal not only facilitates the dissemination of innovative research findings but also ensures that crucial insights are freely accessible to the global scientific community. With an impressive ranking of Q1 in both Cancer Research and Oncology, and a commendable Scopus rank that places it in the top 15% of its field, npj Precision Oncology is dedicated to advancing our understanding of personalized cancer therapies through high-quality research. Catering to professionals, researchers, and students alike, this journal aims to bridge the gap between laboratory science and clinical application, paving the way for transformative approaches in oncology. As the landscape of cancer treatment evolves, npj Precision Oncology remains a crucial platform for fostering collaboration and sparking ideas that can significantly impact patient care.
GENETICS
Transforming Ideas into Genetic BreakthroughsGENETICS, published by the Genetics Society of America, stands as a preeminent journal in the field of genetics, with a keen focus on advancing the understanding of genetic principles and their implications across various biological systems. Since its inception in 1945, the journal has played a pivotal role in disseminating groundbreaking research, maintaining a Q1 ranking in the genetics category as of 2023, positioning it among the top tier of academic publications. While access to the journal is not open, it continues to attract a global readership of researchers, professionals, and students eager to engage with high-quality, peer-reviewed articles that span both classical and contemporary genetics. With its publication history covering critical decades from 1945 to 2024, GENETICS is not just a repository of scientific knowledge but a vibrant forum for the exchange of ideas that drive the field forward. The journal’s commitment to excellence is demonstrated by its strategic coverage of pertinent topics, assuring its relevance for future generations of scholars.